New draft guidelines recently issued by the federal Office for Human Research Protections (OHRP) regarding the evaluation and disclosure of risks in comparative-effectiveness research (CER) fail to clarify current federal policy. If adopted, the result of this approach will be consent forms that make research seem riskier than it truly is and make existing practices seem safer than they truly are. Read more here. (Source: The New England Journal of Medicine, 11/19/14).
You are here: / / New Draft Guidelines Involving Risks In Comparative-Effectiveness Research – A Confusing Clarification